Skip to content

Public FDA record

Z-1915-2016: GE Revolution CT The system is intended for head, whole body, cardiac and vascular X-ray Computed Tomogr

Recall record Z-1915-2016 for GE Healthcare, LLC. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1915-2016
Company in FDA record
GE Healthcare, LLC
FDA record creation date
Jun 6, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

GEHC has become aware of a potential safety issue in the Revolution CT Patient Table that can result in unintended motion in cases involving large patients. The Revolution CT cradle can descend on its own after activation by the user. This can put the patient at risk for harm. The harm can involve the impinging or crushing of a hand if caught between the cradle and CT inner gantry bore. No injurie

Source facts

Action
The firm, GE Healthcare, sent an "Urgent Medical Device Correction" letter ,GEHC Ref# 25468, dated May 9, 2016 to its Consignees. The letter was addressed to Hospital Administrators / Risk Managers, Radiology Department Managers & Radiologists. The letter described the Safety Issue, Safety Instructions, Affected Product Details, Product Correction & Contact Information. The consignees were instructed to ensure that all potential users in your facility are made aware of this safety notification and the recommended actions; continue to use your Revolution CT product; follow the Patient Positioning warning outlined in the Revolution CT User Manual; to prevent pinching or crushing of the patients extremities, keep the patients hands and feet away from the edge of the moving table top/cradle and its surrounding equipment, or between table base and side panels of the table; and take special care when positioning physically large patients. If you have any questions or concerns regarding this notification, please contact GE Healthcare Service at 1-800-437-1171 or your local Service Representative.
Initiated
2016-05-09
Root cause
Process control
Terminated
2018-09-04
Distribution
Worldwide Distribution: US (nationwide) including states of: AL, CA, CT, FL, GA, HI, IL, IN, KS, NE, NY,NC, OH, OR, PA, TN, TX, UT, A, WA, WI; and countries of: Australia, Belgium, Brazil, Canada, China, Denmark, Estonia, France, Germany, Hong Kong, Indonesia, Italy, Japan, Korea (Republic of), Kuwait, Mexico, New Zealand, Norway, Peru, Poland, Saudi Arabia, Singapore, Spain, Sweden, Switzerland, Taiwan, United Arab Emirates, and United Kingdom.
Recall number
Z-1915-2016
Recall status
Terminated
CDRH record ID
146710
FDA record created
2016-06-06
Recall event number
74196

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗